TABLE 3.
Characteristic | Data |
---|---|
Age at procedure, median (range), yrs | 34 (13–68) |
Intervention category, n | |
Surgery, reoperation | 13 |
Surgery, first operation | 2 |
RFA | 4 |
Disease location per patient, n (%) | |
Abdominal metastases | |
Liver | 3 (17.6%) |
Retroperitoneal | 14 (82.4%) |
Thoracic metastases | 2 (11.8%) |
Bony metastases | 6 (35.3%) |
No. tumors per disease location, n (range) | |
Abdomen | 32 (1–6) |
Bone | 128 (0–76) |
Thoracic | 4 (0–3) |
Preoperative pharmacotherapy, n (%)* | |
None† | 2 (10.5%) |
1 drug | 3 (15.8%) |
2 drugs | 9 (47.4%) |
>3 drugs | 5 (26.3%) |
Postoperative biochemical response, n (%) | |
Partial biochemical response‡ | 11 (57.9%) |
Complete biochemical remission§ | 6 (31.6%) |
Drugs included alpha-blockers, beta-blockers, calcium channel blockers, and metyrosine.
Pharmacotherapy refused by a patient.
Partial biochemical response was defined as having at least 1, but not all, biochemical laboratory values returning to the normal range postoperatively.
Complete biochemical remission was defined when all indicative laboratory values returned to the normal range postoperatively.